Gene therapy - Its potential in surgery

Annals of the Royal College of Surgeons of England

Volumn 84, Issue 5, 2002, Pages 297-301

  Gojo, Satoshi ^a   Yamamoto, Shin ^a   Patience, Clive ^a   LeGuern, Christian ^a   Cooper, David K C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cancer; Cardiovascular disease; Gene therapy; Surgery; Transplantation

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; FAS LIGAND; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PRODRUG; PROTEIN P53; RETROVIRUS VECTOR; VASCULOTROPIN; VIRUS VECTOR;

BRAIN CANCER; CANCER; CANCER SURGERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SURGERY; CLINICAL TRIAL; FRACTURE HEALING; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; MEDICAL RESEARCH; NONHUMAN; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; REVIEW; SURGEON; VIRAL GENE DELIVERY SYSTEM; WOUND HEALING;

ADENOVIRIDAE; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; FRACTURE HEALING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; NEOPLASMS; RETROVIRIDAE; TRANSPLANTATION; WOUND HEALING;

EID: 0036743059     PISSN: 00358843     EISSN: None     Source Type: Journal    
DOI: 10.1308/003588402760452367     Document Type: Review

References (24)

1. Anderson WF. Prospects for human gene therapy. Science 1984; 226: 401-9.
2. Recombinant DNA Advisory Committee, National Institutes of Health, December 8-10, 1999. Human Gene Ther 2000; 11: 1591-621.
3. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998; 98: 2800-4.
4. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413-7.
5. Rubin J, Galanis E, Pitot HC, Richardson RL, Burch PA, Charboneau JW et al. Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7. Gene Ther 1997; 4: 419-25.
6. Porteous DJ, Dorin JR, McLachlan G, Davidson-Smith H, Davidson H, Stevenson BJ et al. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther 1997; 4: 210-8.
7. Anderson WF. Human gene therapy. Nature 1998; 392 (Suppl): 25-30.
8. Rosenberg SA, Packard BS, Aebersold PM, Solomon D, Topalian SL, Toy ST et al. Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med 1988; 319: 1676-80.
9. Editorial. The ADA human gene therapy clinical protocol. Hum Gene Ther 1990; 1: 327-62.
10. Baumgartner I, Pieczek A, Manor O, Blair R, Kearney M, Walsh K et al. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 1998; 97: 1114-23.
11. Laiteinen M, Hartikainen J, Hiltunen MO, Eranen J, Kiviniemi M, Narvanen O et al. Catheter-mediated VEGF gene transfer to human coronary arteries after angioplasty. Safety results from phase I Kuopio angioplasty gene transfer trial (KAT trial). Circulation 1998; 98, I-322.
12. Mann MJ, Whittemore AD, Donaldson MC, Belkin M, Conte MS, Polak JF et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomized, controlled trial. Lancet 1999; 354: 1493-8.
13. Federal Register Announcement. Hum Gene Ther 1998; 9: 1799-843.
14. Herman JR, Adler HL, Aguilar-Cordova E, Rojas-Martinez S, Woo S, Timme TL et al. In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial. Hum Gene Ther 1999; 10: 1239-49.
15. Ram Z, Culver KW, Oshiro EM, Viola JJ, De Vroom HL, Otto E et al. Therapy of malignant brain tumours by intratumoural implantation of retroviral vector-producing cells. Nat Med 1997; 3:1354-61.
16. Stewart AK, Lassam NJ, Quirt IC, Bailey DJ, Rotstein LE, Krajden M et al. Adenovector-mediated gene delivery of interleukin-2 in metastatic breast cancer and melanoma: results of a phase I clinical trial. Gene Ther 1999; 6: 350-63.
17. Saleh M, Stacker SA, Wilks AF. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res 1996; 56: 393-401.
18. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carraso CH, Ferson DZ et al. Retrovirus-mediated wild-type p53 gene transfer to tumours of patients with lung cancer. Nat Med 1996; 2: 985-91.
19. Nesbit KW, Herlyn M, Radu A, Adzick NS, Crombleholme TM. Adenoviral-mediated overexpression of platelet-derived growth factor-B corrects ischemic wound healing. J Invest Dermatol 1999; 113: 375-83.
20. Breitbart AS, Mason JM, Urmacher C, Barcia M, Grant RT, Pergolizzi RG et al. Gene-enhanced tissue engineering; applications for wound healing using cultured dermal fibroblasts transduced retrovirally with the PDGF-B gene. Ann Plast Surg 1999; 43: 632-9.
21. Sun L, Xu L, Chang H, Henry FA, Miller RM, Nielsen TB. Transfection with α-FGF cDNA improves wound healing. J Invest Dermatol 1997; 108: 313-8.
22. Baltzer AW, Lattermann C, Whalen JD, Wooley P, Weiss K, Grimm M et al. Genetic enhancement of fracture repair; healing of an experimental segmental defect by adenoviral transfer of the BMP-s gene. Gene Ther 2000; 7: 734-9.
23. Gojo S, Cooper DKC, Iacomini J, LeGuern C. Gene therapy in transplantation. Transplantation 2000; 69: 1995-9.
24. Goldspink G. Gene therapy in cell engineering. Ann R Coll Surg Engl 1997; 79: 245-9.